title: ["Rather overweight and mentally present...". Patients evaluate clozapine].
abstract: OBJECTIVE
  Subjective evaluations by schizophrenic patients of clozapine treatment were assessed as part of an exploratory study.
  
  
  METHODS
  A problem-centred interview was carried out with 80 patients at discharge from in-patient or day hospital treatment.
  
  
  RESULTS
  In addition to expected effects (improvement or stabilisation of one's state of mental health, antipsychotic effects), patients surprisingly often highlighted clozapine's calming and relaxing effect as well as improved sleep as particularly positive. While more than half of the respondents expected a worsening of their condition in case they stopped taking their medication, only every fifth patient feared a relapse. Among the negative effects, fatigue and sedation were cited by far the most often. The absence of extrapyramidal side effects was clearly noted as an advantage of clozapine. Only every tenth of those questioned was aware of the risks for the haemotopoietic system associated with the drug. With regard to the obligatory blood tests, a surprisingly large number of patients was indifferent or stated that they had no opinion on the matter.
  
  
  CONCLUSIONS
  Possible implications for patient information and compliance will be discussed.
authors.affiliation: Klinik und Poliklinik für Psychiatrie, Universität Leipzig.
authors.forename: K
authors.initials: K
authors.lastname: Boitz
authors.forename: M C
authors.initials: MC
authors.lastname: Angermeyer
authors.forename: W
authors.initials: W
authors.lastname: Löffler
authors.forename: P
authors.initials: P
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Priebe
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001294:Attitude to Health; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010351:Patient Discharge; D010353:Patient Education as Topic; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine